Clinical Trial Update: Prevention of Linear Growth Failure in Infants and Young Children With Lipid-based Nutrient Supplements (iLiNS-DOSE) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on preventing linear growth failure in infants and young children using lipid-based nutrient supplements (iLiNS-DOSE); the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malnutrition

Drugs mentioned

• lipid-based nutrient supplement (iLiNS-DOSE)

Snippet

Sponsor: Tampere University | Conditions: Malnutrition | Phase 3 | Status: COMPLETED